1. Home
  2. UCTT vs RCUS Comparison

UCTT vs RCUS Comparison

Compare UCTT & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UCTT
  • RCUS
  • Stock Information
  • Founded
  • UCTT 1991
  • RCUS 2015
  • Country
  • UCTT United States
  • RCUS United States
  • Employees
  • UCTT N/A
  • RCUS N/A
  • Industry
  • UCTT Semiconductors
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • UCTT Technology
  • RCUS Health Care
  • Exchange
  • UCTT Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • UCTT 1.2B
  • RCUS 1.2B
  • IPO Year
  • UCTT 2004
  • RCUS 2018
  • Fundamental
  • Price
  • UCTT $28.75
  • RCUS $16.47
  • Analyst Decision
  • UCTT Strong Buy
  • RCUS Buy
  • Analyst Count
  • UCTT 3
  • RCUS 8
  • Target Price
  • UCTT $39.00
  • RCUS $26.00
  • AVG Volume (30 Days)
  • UCTT 416.6K
  • RCUS 1.2M
  • Earning Date
  • UCTT 10-28-2025
  • RCUS 11-05-2025
  • Dividend Yield
  • UCTT N/A
  • RCUS N/A
  • EPS Growth
  • UCTT N/A
  • RCUS N/A
  • EPS
  • UCTT N/A
  • RCUS N/A
  • Revenue
  • UCTT $2,141,100,000.00
  • RCUS $262,000,000.00
  • Revenue This Year
  • UCTT N/A
  • RCUS N/A
  • Revenue Next Year
  • UCTT $4.45
  • RCUS N/A
  • P/E Ratio
  • UCTT N/A
  • RCUS N/A
  • Revenue Growth
  • UCTT 14.28
  • RCUS 6.07
  • 52 Week Low
  • UCTT $16.66
  • RCUS $6.50
  • 52 Week High
  • UCTT $40.64
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • UCTT 55.85
  • RCUS 67.96
  • Support Level
  • UCTT $25.56
  • RCUS $15.38
  • Resistance Level
  • UCTT $30.41
  • RCUS $17.67
  • Average True Range (ATR)
  • UCTT 1.49
  • RCUS 1.13
  • MACD
  • UCTT -0.06
  • RCUS 0.18
  • Stochastic Oscillator
  • UCTT 62.05
  • RCUS 74.91

About UCTT Ultra Clean Holdings Inc.

Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: